The present invention provides genomic markers for determining the predisposition of prostate cancer to become metastasized.

 
Web www.patentalert.com

< Nucleic acids encoding interphotoreceptor matrix proteins

> Nucleic acids encoding chimeric T cell receptors
~ 00494